To see the effect of 2 medicines namely panchasama churna and kshara basti in the treatment of disease Amavata(Rheumatoid Arthritis)Â
- Conditions
- Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor
- Registration Number
- CTRI/2022/04/042053
- Lead Sponsor
- Ayurvedic and Unani Tibbia College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Patient willing to participate in the trial.
2 The patients between the age group of 18 to 60 years.
3 Patients having classical features of Amavata like Angamarda(malaise), Aruchi(Anorexia), Trishna(excessive thirst), Alasya(laziness), Gaurava(heaviness of body), Jwara(fever), Apaka(indigestion), Angashoonata(swelling).
4 Pt. who is taking anti inflammatory(analgesics) will be included after a washout period of 7days provided they are diagnosed with RA in last 1 year.
5 The patients should fulfil the 2010 ACR(American College of Rheumatology) EULAR (European League Against Rheumatism) criteria for rheumatoid arthritis.
1 Patients having Severe crippling bone deformity.
2 Pt. who are on DMRDs and Biologicals are not included in study.
3 Patients having another type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylitis etc.
4 Patients having associated Cardiac disease, Pulmonary Tuberculosis.
5 Patients with genetic and endocrinal disorder, chronic disorder like Paralysis, Cancer, Renal failure, Hepatic failure.
6 H/O of hypersensitivity of any trial drug.
Patients taking antibiotic therapy for any systemic illness within 2 months.
7 Pregnant women and lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 The assessment of effect of Panchsama churna on the cardinal features <br/ ><br>2 The assessment of effect of Ksharbasti karma <br/ ><br>3 The assessment of effect of Ksharbasti karma along with Panchsama churna <br/ ><br>4 Improvement in subjective parameters like <br/ ><br>1 Pain in joints <br/ ><br>2 swelling in joints <br/ ><br>3 Tenderness of joints <br/ ><br>4 Stiffness of jointsTimepoint: At baseline and after 12 weeks
- Secondary Outcome Measures
Name Time Method Assessment will be done clinically on basis of improvement in objective parameters like RA Factor, CRP, ESR and Anti-CCP.Timepoint: At baseline and after 12 weeks